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Roles of prostaglandin E receptors in mesangial cells under high glucose concentrations accumulate elevated amounts
high-glucose conditions. of extracellular matrix proteins, which is one of the major
Background. High glucose reportedly stimulates prostaglan- pathological changes associated with diabetic glomerulo-
din (PG) E2 production and DNA synthesis in mesangial cells pathy [3, 4]. It has been reported that glomeruli isolated(MCs). However, the pathophysiological significance of PGE2
from streptozotocin (STZ)-induced diabetic rats andin MCs has remained unclear.
Methods. The effects of prostanoids on [3H]-thymidine up- MCs cultured at high glucose concentrations produce
take and cAMP production in rat MCs cultured with 5.6 mm significantly greater amounts of prostaglandins (PGs)
glucose, 25 mm glucose, or 5.6 mm glucose supplemented with [5–7]. The increases of urinary thromboxane (TX) B2 and19.4 mm mannitol were examined. The gene expression of PGE2 6-keto-PGF1a excretions are found in STZ rats comparedreceptor (EP) subtypes in MCs was analyzed with Northern
with controls [8]. An overproduction of PGE2 has beenblotting techniques.
Results. Northern blotting indicated EP1 and EP4 gene expres- reported to increase the glomerular filtration rate (GFR)
sion in MCs. EP1 agonists and PGE2 stimulated [3H]-thymidine in the early stages of diabetic nephropathy [9]. Craven,
uptake in MCs. EP1 antagonists dose dependently attenuated Caines, and DeRubertis also observed that the glomeru-
high-glucose–induced [3H]-thymidine uptake, which suggests
lar hyperfiltration of rats during the first two weeks afterEP1 involvement, by an increase in intracellular Ca21, in DNA
induction of diabetes by STZ was mediated by a PG-synthesis of MCs. On the other hand, forskolin, db-cAMP, and
11-deoxy-PGE1, an EP4 /EP3 /EP2 agonist, significantly decreased dependent mechanism [10]. On the other hand, Barnett
DNA synthesis in MCs. These inhibitory effects are thought et al and Bank et al questioned the role of PGs in mediat-
to be mediated via EP4 as a result of an increase in cAMP ing increased GFR and changes in renal hemodynamics
synthesis. The effects via EP4 seem to be particularly important during early diabetes [11, 12]. Therefore, the role of thebecause PGE2-induced cAMP synthesis was significantly atten-
prostanoid system in the initiation and progression ofuated in the high-glucose group compared with the mannitol
diabetic nephropathy is still unclear.group, in which [3H]-thymidine uptake did not increase in spite
of augmented PGE2 production. Recently, some investigators claim the significance of
Conclusion. The increase in DNA synthesis in MCs under MC proliferation in the early stages of diabetic glomeru-
high-glucose conditions can be explained, at least in part, by
lopathy [13]. That is, mesangial hypercellularity and fol-the high-glucose–induced inhibition of cAMP production via
lowing transforming growth factor-b (TGF-b) produc-EP4, which augments EP1 function in conjunction with the
tion precede an increase in extracellular matrix proteinsoverproduction of PGE2.
and glomerular sclerosis, which are characteristics of dia-
betic nephropathy. Although the pathophysiological sig-
nificance of MC proliferation in diabetic glomerulopathyIn diabetes mellitus, hyperglycemia and vasoactive sub-
is still controversial, a high glucose concentration is re-stances are believed to be triggers of the development of
ported to increase DNA synthesis in MCs. Mahadevanglomerulopathy [1, 2]. Mesangial cells (MCs) cultured at
et al propose that PG and hyaluronan production in re-
sponse to a raised glucose environment can contribute to
Key words: PGE2, EP receptors, DNA synthesis, cAMP mesangial hypercellularity [14]. However, PGE2 is known
to increase cAMP generation in MCs, which inhibitsReceived for publication July 1, 1998
cell proliferation in most tissues. Precise mechanisms ofand in revised form February 11, 1999
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exhibit various activities through binding to specific cell membranes expressing mouse EP1 receptor revealed that
equilibrium inhibition constants (Ki) of SC-51322 andsurface receptors. However, little attention has been
given to the relationship between the prostanoid recep- ONO-AE-628 were 7.9 nm and 1.3 nm, respectively.
Phorbol 12-myristate 13-acetate (PMA; Sigma) was usedtors and diabetes mellitus. Recently, cDNAs for all of
the prostanoid receptors have been cloned. At least four for the activation of protein kinase C (PKC). Cells were
treated with forskolin (Sigma) to activate adenylate cy-subtypes of PGE receptors, EP1, EP2, EP3, and EP4, have
been identified so far. EP1 is associated with calcium clase. Dibutyryl cAMP (db-cAMP) was obtained from
Sigma.mobilization, EP2 and EP4 with stimulation of adenylate
cyclase, and EP3 with the inhibition of adenylate cyclase
Experimental protocolor the stimulation of phosphoinositol turnover [15]. In
this study, we examined the gene expression of PGE When reaching 80% confluency, MCs were exposed
to DMEM containing 20% FCS supplemented with (a)receptor subtypes in rat MCs using Northern blot analy-
ses and tried to elucidate the pathophysiological roles 5.6 mm glucose (normal-glucose group), (b) 25 mm glu-
cose (high-glucose group), or (c) 5.6 mm glucose plusof prostanoid receptors by evaluating the effects of
prostanoids on DNA synthesis and cAMP generation at 19.4 mm mannitol (mannitol group), which contained an
osmotic load equivalent to the high-glucose group forhigh glucose concentrations.
five days in an incubator at 378C. To examine the effects
of prostanoid analogues and/or glucose on [3H]-thymi-
METHODS
dine uptake, PGE2 production and cAMP synthesis, the
Cell culture treated MCs were subcultured in 24-well plates (Corn-
ing) at a density of 1 3 104 cells per well. Two days afterMesangial cells were derived from glomeruli isolated
from 17-week-old male Wistar Kyoto rats (WKY) with a subculture, these cells were analyzed.
graded sieving technique [16–18]. Cells were cultured in
Measurements of [3H]-thymidine incorporation10 cm culture dishes (Corning Incorporated, Corning, NY,
into DNAUSA) in Dulbecco’s modified Eagle’s medium (DMEM;
GIBCO BRL, Grand Island, NY, USA) containing 5.6 mm Mesangial cells were transferred in 24-well cell culture
plates at a density of 1 3 104 cells per well. After 48glucose and 20% fetal calf serum (FCS; Irvine Scientific
Sales, Santa Ana, CA, USA) with 100 unit/ml of penicil- hours, these cells were maintained in a quiescent state
by exposure to DMEM supplemented with 0.2% FCSlin and 100 mg/ml of streptomycin. Cells were allowed
to grow at 378C in a humidified atmosphere containing for 72 hours. Next, MCs were stimulated with EP ago-
nists, EP antagonists, forskolin, or db-cAMP and were5% CO2. MCs were identified by immunofluorescence
techniques [18]. All of the experiments were performed then pulsed with 1 mCi of [3H]-thymidine (Amersham,
Arlington Heights, IL, USA) per well for the last 48on cells between the seventh and ninth passages.
hours. Cells were washed twice with ice-cold Dulbecco’s
Materials phosphate-buffered saline (PBS) and once with ice-cold
10% trichloroacetic acid (TCA). Then they were incu-Sulprostone (EP1 and EP3 agonist; Cayman Chemical
Company, Ann Arbor, MI, USA), butaprost (EP2 ago- bated for 30 minutes. After discarding TCA, these cells
were washed twice with ice-cold 95% ethanol and werenist; Dr. P.J. Gardiner, Bayer U.K. Ltd., Research De-
partment, Slough, England), M&B28767 (EP3 and EP1 solubilized with 0.25 m NaOH for two hours. The cell
lysate was neutralized with neutralizing buffer (1 magonist; ONO Pharmaceutical, Osaka, Japan), 11-deoxy-
PGE1 (EP4, EP3, and EP2 agonist; Cayman Chemical Tris:2.5 m HCl 5 2:1). Radioactivity was measured by
liquid scintillation spectroscopy.Company), or PGE2 (Sigma Chemical Co., St. Louis,
MO, USA) was added to the culture media of MCs. The
Determinations of intracellular Ca21 concentrationspecificity of each analogs expressed as Ki (nm) for EP1,
EP2, EP3, and EP4 are as follows: sulprostone, 94, The intracellular Ca21 concentration ([Ca21]i) was
measured fluorometrically using fura-2 acetomethylester.100,000, 0.7, 43600; butaprost, 38700, 65, 11815, 15700;
M&B28767, 508, 1370, 0.3, 24; 11-deoxy-PGE1, 2980, 30, (fura-2/AM; Sigma). Confluent monolayer MCs on glass
cover slips (diameter 1.3 cm) were loaded with 5 mm fura-3.2, 1.1; PGE2, 22, 6.8, 0.9, 1.1, respectively [19]. SC-
51322 [20] or ONO-AE-628 (ONO Pharmaceutical, 2/AM for 60 minutes at 378C in serum-free DMEM. The
cover slips were inserted diagonally in a quartz cuvetteOsaka, Japan) was used as a selective antagonist for EP1.
The concentrations of SC-51322 or ONO-AE-628, which filled with 2 ml of Krebs-Henseleit-Hepes buffer (KHH).
KHH, pH 7.4, containing 140 mm NaCl, 4.7 mm KCl, 2.2inhibit 100 nm PGE2-induced elevation of Ca21 in CHO
cells expressing mouse EP1 (96% homology with rat EP1) mm CaCl2, 1.2 mm MgCl2, 1.2 mm KH2PO4, 11 mm glucose,
15 mm HEPES, and 0.2% fatty acid-free bovine serum[21] by 50% were 60 nm and 310 nm, respectively. The
competition study for [3H]-PGE2 binding to CHO cell albumin. MCs were pretreated with various concentra-
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tions of EP1 antagonists or vehicle for one minute and [24]. The cDNA fragment was sequenced by both strands.
HindIII-EcoRI fragment of prEPR1 was used as a ratwere subsequently stimulated with 2 3 1026 m PGE2.
The calibration of Ca21-dependent fluorescence was per- EP4 cDNA probe [25]. The nucleotide sequence and the
direction of the amplified DNA fragment subcloned intoformed by adding Digitonin (Tokyo Kasei Kogyo, Tokyo,
Japan) to maximum fluorescence (Fmax), followed by che- a plasmid (pGEM-T-Easy; Promega) were confirmed by
sequencing both strands using EP1-specific primers andlation of Ca21 to minimum fluorescence (Fmin) with 0.5 m
ethylene glycol-bis (b-aminoethyl ether)-N,N,N9,N9-tetra- universal SP6 and T7 primers. The nucleotide sequence
was consistent with that of rat EP1 cDNA [23]. Next, toacetic acid (EGTA). Cytosolic Ca21 concentration was
calculated as [Ca21] (nm) 5 Kd 3 (X2Rmin)/(Rmax2X) 3 construct the plasmid DNA to the linear form, the plas-
mid DNA was digested by restriction enzyme BamHI,Fmin/Fmax, employing a Kd of fura-2 for Ca21 of 224 nm [22].
which was located in the poly cloning site of the plasmid
Assay for cAMP at the 59-end of the EP1 cDNA. The digested plasmid
DNA was electrophoresed on an agarose gel and con-Two days after subculture in 24-well plates at a density
of 1 3 104 cells per well, MCs were washed twice with firmed the DNA at the predicted size. We extracted the
digested plasmid DNA from the agarose gel and usedserum-free DMEM and 500 ml of DMEM containing
0.5 mm 3-isobutyl-1-methylxanthine (IBMX; Sigma), and the DNA to prepare the rat EP1 antisense RNA. Further-
more, the prepared 32P-EP1 antisense RNA was electro-0.1% bovine serum albumin was added. After preincuba-
tion for 10 minutes at 378C, MCs were stimulated with phoresed on an agarose gel and confirmed as a single
band in the expected size of approximately 1.2 kb.various concentrations of the previously mentioned li-
gands for 10 minutes. The incubation was terminated by The filter was hybridized with the 32P-labeled probe
at 428C in 50% formamide, 4 3 standard saline citrateadding 500 ml of ice-cold 12% TCA to each well. After
scraping cells, the solutions were centrifuged for five (SSC), 5 3 Denhardt’s reagent, 0.5% sodium dodecyl
sulfate (SDS), and 100 mg/ml heat-denatured salmonminutes at 48C, and the supernatants were extracted with
water-saturated ether. The cAMP content was measured sperm DNA and then washed at 558C in 0.5 3 SSC and
0.1% SDS. Autoradiography was performed on x-ray filmsusing a specific radioimmunoassay (Yamasa Corp., Tokyo,
Japan) after succinylation. The protein content per well with intensifying screens. As an internal control, the filter
was rehybridized with the human b-actin cDNA probe.was determined with a Biorad protein assay kit (Bio-
Rad Laboratories, Richmond, CA, USA).
Statistical analysis
Determinations of prostaglandin E2 concentration Values were expressed as means 6 se, and the signifi-
cance was analyzed by analysis of variance. A differenceThe amount of PGE2 in the culture medium of MCs
after 48 to 96 hours of incubation was determined by a with P , 0.05 was considered significant.
radioimmunoassay (New England Nuclear, Boston, MA,
USA).
RESULTS
Effects of prostanoid analogues, high glucose, andNorthern blot analyses
cAMP on [3H]-thymidine uptakeTotal RNA was extracted from cultured MCs in the
normal-glucose, high-glucose, or mannitol group using Sulprostone, M&B28767 (1026 m), or PGE2 (1028 m)
significantly stimulated [3H]-thymidine uptake, but buta-the acid guanidinium-phenol-chloroform method. Fifty
micrograms of total RNA per lane were electrophoresed prost did not (Fig. 1A). On the other hand, 11-deoxy-
PGE1 at a concentration of 1026 m significantly sup-on a 1.4% agarose gel and transferred to a nylon mem-
brane filter (Biodyne, Pall BioSupport, Glen Cove, NY, pressed [3H]-thymidine uptake (45%). The dose-depen-
dent effects of sulprostone, butaprost, M&B28767, andUSA) for the detection of EP2 or EP4 mRNA. Poly(A)1
RNA was also prepared by a commercial oligo(dT) selec- 11-deoxy-PGE1 between 10210 m and 1026 m are shown
in Figure 1B. PGE2 at a concentration of 1028 m exhibitedtion method (PolyATtract messenger RNA Isolation
System; Promega Corp., Madison, WI, USA) for EP1. maximal stimulation of [3H]-thymidine incorporation
into DNA between 10210 m and 1026 m (Fig. 1C). UnderTwo micrograms of poly(A)1 RNA per lane was electro-
phoresed on a 1.0% agarose gel and transferred to a high-glucose conditions, [3H]-thymidine uptake was also
increased approximately 2.5-fold compared with the nor-nylon membrane filter as previously reported [23]. The
rat EP2 and rat EP4 cDNA probes and an antisense mal-glucose group (Fig. 2). Sulprostone or PGE2-induced
elevation of DNA synthesis was completely blocked bycRNA probe for rat EP1 were prepared as follows. A
rat EP2 receptor cDNA fragment, bases 159 to 11193, SC-51322 and ONO-AE-628, selective antagonists for
EP1, in the normal glucose group (Fig. 3). In addition,was prepared by reverse transcription-polymerase chain
reaction using a poly(A)1 RNA from the rat kidney high-glucose–induced DNA synthesis was dose depen-
dently suppressed by SC-51322 (Fig. 4A) or ONO-AE-according to the nucleotide sequence of rat EP2 cDNA
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Fig. 1. (A) [3H]-thymidine incorporation into DNA of rat mesangial
cells (MCs) under normal-glucose conditions with the addition of sul-
prostone (EP1 and EP3 agonist), butaprost (EP2 agonist), M&B28767
(EP3 and EP1 agonist), or 11-deoxy-PGE1 (EP4, EP3, and EP2 agonist)
at a concentration of 1026 M or 1028 M PGE2. The values are expressed
as means 6 se for four experiments. *P , 0.05; **P , 0.01 compared
with the control. (B) Sulprostone (h) and M&B28767 (j) dose depen-
dently stimulated [3H]-thymidine uptake of rat MCs; however, butaprost
(s) had no effects between 10210 and 1026 m. In contrast, 11-deoxy-
PGE1 (d) dose dependently inhibited DNA synthesis of MCs. The
values are expressed as means 6 se for four experiments. *P , 0.05;
**P , 0.01 compared with the control. (C) The effects of PGE2 ranging
from 10210 to 1026 M on [3H]-thymidine incorporation into DNA of rat
MCs under normal-glucose conditions. The values are expressed as
means 6 se for six experiments. *P , 0.01 compared with the control.
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Fig. 2. [3H]-thymidine incorporation into DNA of rat mesangial cells
(MCs) with 5.6 mM glucose (normal-glucose group), 25 mM glucose
(high-glucose group) or 5.6 mM glucose plus 19.4 mM mannitol (mannitol
group). MCs were incubated with 1 mCi of [3H]-thymidine per well for
48 hours. The values are expressed as means 6 se for six experiments.
*P , 0.001 compared with the normal-glucose or mannitol group.
Fig. 4. The dose-dependent effects of SC-51322 (A) or ONO-AE-628
(B) on [3H]-thymidine incorporation into DNA of rat mesangial cells
(MCs) with 5.6 mM glucose (normal-glucose group; s), 25 mM glucose
(high-glucose group; d), or 5.6 mM glucose plus 19.4 mM mannitol
(mannitol group; n). The values are expressed as means 6 se for eight
experiments. *P , 0.05; **P , 0.01 compared with each control.
Fig. 3. In the normal glucose group, 1026 M sulprostone or 1028 M
PGE2-induced stimulation of DNA synthesis of rat mesangial cells
(MCs) was completely blocked by EP1-selective antagonists (SC,
1027 M SC-51322, AE, 1026 M ONO-AE-628). The values are expressed
as means 6 se for four experiments. *P , 0.05; **P , 0.01; ***P , DNA synthesis of MCs in the normal-glucose, high-glu-0.001 compared with sulprostone or PGE2 alone.
cose, and mannitol groups (Fig. 5 A, B).
Effects of EP1 antagonists on a prostaglandin
E2-induced increase in intracellular calcium628 (Fig. 4B), although these EP1 antagonists did not
have significant effects under normal-glucose conditions. Prostaglandin E2 at a concentration of 2 3 1026 m
stimulated [Ca21]i in MCs, which was almost completelyIn the mannitol group, [3H]-thymidine uptake was not
significantly stimulated (Figs. 2 and 4). inhibited by 1 3 1026 m SC-51322 or 1 3 1025 m ONO-
AE-628 (Fig. 6). [Ca21]i in MCs was not affected whenForskolin or db-cAMP dose dependently inhibited
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of up to 1026 m had no effect (Fig. 7A). 11-deoxy-PGE1
dose dependently stimulated cAMP production in MCs
between 1028 m and 1026 m (Fig. 7B). PGE2-induced
cAMP accumulation also exhibited a dose-dependent
increase between 10210 m and 1026 m (Fig. 7C). PGE2 at
a concentration of 1026 m stimulated cAMP synthesis
by threefold compared with the control in the normal-
glucose group. In the absence of prostanoid receptor
agonists, cAMP generation was not affected after the
exposure of high glucose or mannitol for 10 minutes.
However, cAMP production by 11-deoxy-PGE1 between
1028 m and 1026 m or PGE2 between 10210 m and 1026 m
was suppressed by 76 to approximately 86% and 47 to
approximately 65% under high-glucose conditions, re-
spectively (Fig. 7 B, C). The mannitol group did not
exhibit these inhibitory effects.
Prostaglandin E2-induced cAMP production was dose
dependently suppressed by PMA at concentrations from
1 to 100 nm (Fig. 8A). cAMP production by 1026 m of
PGE2 decreased by 49% when treated with PMA at a
concentration of 10 nm. PMA at a concentration of 10
nm also suppressed forskolin-induced cAMP production
by 51% (Fig. 8B).
Prostaglandin E2 production by mesangial cells
Prostaglandin E2 accumulation in the culture media
after 48 to 96 hours of incubation under three different
conditions is shown in Figure 9. PGE2 production was
2.9 nm in the high-glucose and the mannitol group and
was 1.5 nm in the normal-glucose group after 96 hours
of incubation.
Gene expression of prostaglandin E receptor subtypes
in rat mesangial cells
The gene expression of PGE receptor subtypes in the
normal-glucose, high-glucose, or mannitol group is shown
in Figures 10 and 11. Northern blot analyses revealed 8
kb and 6 kb EP1 mRNA expression in rat MCs. EP4
Fig. 5. Effects of endogenous or exogenous cAMP on [3H]-thymidine mRNA (3.5 kb) was also present. EP2 mRNA was notincorporation into DNA of rat mesangial cells (MCs). (A) Forskolin
detected in MCs, although a positive band was observeddose dependently suppressed DNA synthesis of MCs treated with 0.5
mm IBMX under the normal-glucose (s), high-glucose (d), or mannitol in the rat lung (data not shown). There was no significant
(n) groups. (B) Dose-dependent inhibitory effects of DNA synthesis difference in EP1 or EP4 mRNA concentrations amongby db-cAMP were also shown. The values are expressed as means 6
the three groups.se for four experiments. *P , 0.05; **P , 0.01; ***P , 0.001 compared
with each control.
DISCUSSION
It has been reported that glomeruli isolated from dia-
only SC-51322 or ONO-AE-628 was added (data not betic rats or MCs cultured under high-glucose conditions
shown). produce significantly greater amounts of immunoreac-
tive PGE2, PGF2a, TXB2, and 6-keto-PGF1a, a stable me-
Effects of prostanoid analogues and high glucose on tabolite of PGI2, than controls [5–7]. In this study, immu-
cAMP production noreactive PGE2 was also detected in the culture media,
Prostaglandin E2 (10210 m) or 11-deoxy-PGE1 (1028 m) and it was elevated two-fold (2.9 nm) under high-glucose
significantly increased cAMP production in MCs, whereas conditions. In the high-glucose group, [3H]-thymidine
uptake was stimulated 2.5-fold compared with the nor-sulprostone, butaprost, or M&B28767 at concentrations
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Fig. 6. Inhibitory effects of EP1 selective antagonists (SC-51322 and ONO-AE-628) on PGE2-induced increase in intracellular calcium ([Ca21]i).
Rat mesangial cells (MCs) were treated with various concentrations of each EP1 antagonist for one minute and were subsequently exposed to 2 3
1026 m PGE2.
mal glucose group. A part of this increment was ex- mesangial compartment of the glomerulus observed in
diabetic glomerulopathy result from increases in matrixplained by the PGE2/EP1 system in rat MCs because SC-
51322 or ONO-AE-628, specific antagonists for EP1, dose production and probably in the number of MCs [27]. The
activation of mitogen-activated protein kinase (MAPK)dependently attenuated the increased [3H]-thymidine
uptake by cultured MCs at high glucose concentrations. cascade in glomerular MCs cultured under high-glucose
conditions [28] may be one of the mediators of mesangialGlomerular MCs cultured at high glucose concentrations
accumulate elevated amounts of extracellular matrix hypercellularity. We also found that PGE2 at 1028 m or
1027 m significantly stimulates [3H]-thymidine uptake inproteins, including fibronectin, laminin, and type IV col-
lagen [3, 4]. McLennan et al reported that a high glucose quiescent MCs under normal-glucose conditions. PGE2 at
1028 m caused the greatest level of [3H]-thymidine incorpo-concentration inhibited mesangium matrix degradation
[26]. The significance of MC proliferation in diabetic ration into DNA of rat MCs, which suggests that endoge-
nous PGE2 production has a significant effect on theglomerulopathy is not clear; however, increases in the
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Fig. 7. (A) Effects of sulprostone, butaprost, M&B28767, 11-deoxy-
PGE1, or PGE2 at a concentration of 1026 M on cAMP production in
rat mesangial cells (MCs) cultured with 5.6 mM glucose (normal-glucose
group; h), 25 mM glucose (high-glucose group; j) or 5.6 mM glucose
plus 19.4 mM mannitol (mannitol group; ). MCs were stimulated
with these ligands for 10 minutes. Neither glucose concentration nor
osmolarity affected cAMP generation in the absence of these PGE
receptor agonists. The values are expressed as means 6 se for six
experiments. *P , 0.05; #P , 0.01 compared with each control. (B)
Dose-dependent stimulation of cAMP production in rat MCs by 11-
deoxy-PGE1 between 1028 m and 1026 m. Values are expressed as means 6
se for four experiments. *P , 0.05; **P , 0.01; ***P , 0.001 compared
with each control. (C) The effect of exogenous PGE2 on cAMP synthesis
was examined by the addition of 10210 to 1026 m PGE2 in the culture
media. The values are expressed as means 6 se for six experiments.
*P , 0.001 compared with each control. #P , 0.001 normal glucose
group vs. high-glucose group in each concentration.
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Fig. 9. Prostaglandin (PG) E2 production in culture media of rat mesan-
gial cells (MCs) with 5.6 mM glucose (normal-glucose group; s), 25 mM
glucose (high-glucose group; d), or 5.6 mM glucose plus 19.4 mM mannitol
(mannitol group; n) between 48 and 96 hours after subculture. The
values are expressed as means 6 se for four experiments. *P , 0.05
compared with the normal-glucose group.
Fig. 10. Northern blot analysis of EP1 mRNA in rat mesangial cells
(MCs) with 5.6 mM glucose (normal-glucose group), 25 mM glucose
(high-glucose group), or 5.6 mM glucose plus 19.4 mM mannitol (mannitol
Fig. 8. (A) Inhibition of 1026 m PGE2-induced cAMP production by group). Two micrograms of poly(A)1 RNA in each lane, isolated from
phorbol 12-myristate 13-acetate (PMA) ranging from 1 to 100 nM for rat MCs, were electrophoresed and hybridized with an antisense cRNA
six hours under normal-glucose conditions. The values are expressed as probe for rat EP1 receptor and with the human b-actin cDNA probe.
means 6 se for six experiments. *P , 0.001 compared with PMA (2)
and 1026 m PGE2. (B) Inhibition of forskolin-induced cAMP generation
by PMA under normal-glucose conditions. Cells were incubated with
1026 m forskolin for 10 minutes after treatment with PMA for six hours.
The values are expressed as means 6 se for eight experiments. *P , Concerning renal EP receptors, Sugimoto et al demon-
0.001 compared with PMA (2) and 1026 m forskolin. strated the presence of EP1, EP3, and EP4 in the mouse
kidney using in situ hybridization [29]. The mRNA for
mouse EP1 was mainly localized to the collecting ducts
from the cortex to the papilla. The mRNA for EP3 wasproliferation of MCs considering the PGE2 concentration
in the culture media. Among other EP agonists, sulpro- located in the tubules in the outer medulla and also in
the distal tubules in the cortex. The mRNA for EP4 wasstone and M&B28767 significantly increased [3H]-thymi-
dine incorporation into DNA of rat MCs. M&B28767, localized to the glomeruli. The distribution of EP2 is
rather limited, and EP2 mRNA was not detected in thean EP3 agonist, has a lower affinity to the EP1 than PGE2
or sulprostone and exhibited the least effect on [3H]- kidney [30]. In human glomeruli, only EP4 mRNA was
detected by in situ hybridization [31]. Although EP1thymidine uptake. These results also indicate that EP1
mediates the stimulating effect of PGE2 on [3H]-thymi- mRNA was not detected in the mouse or human glomer-
uli, we have demonstrated the existence of EP1 mRNAdine uptake in the normal-glucose group.
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inhibit it (Fig. 3). Thus, PGE2 has both stimulating and
inhibiting effects on DNA synthesis, the former of which
is mediated via EP1 and the latter of which via EP4.
Therefore, DNA synthesis induced by PGE2 is affected
by both EP1 and EP4 functions, which resulted in a bipha-
sic response of DNA synthesis in MCs (Fig. 1C). The
dose-dependent inhibitory effect of 11-deoxy-PGE1 on
[3H]-thymidine uptake also supports that the activation
Fig. 11. Northern blot analysis of EP4 mRNA in rat mesangial cells of the EP4/cAMP system attenuates DNA synthesis. In-
(MCs) with 5.6 mM glucose (normal-glucose group), 25 mM glucose terestingly, cAMP synthesis by PGE2 was decreased in(high-glucose group), or 5.6 mM glucose plus 19.4 mM mannitol (mannitol
the high-glucose group but not in the mannitol groupgroup). Fifty micrograms of total RNA in each lane, isolated from rat
MCs, were electrophoresed and hybridized with a rat cDNA probe for compared with the normal-glucose group. Therefore, the
EP4 receptor and with the human b-actin cDNA probe. difference in cAMP synthesis by the PGE2/EP4 system
between the high-glucose and mannitol group may ac-
count for the increased [3H]-thymidine uptake under
high-glucose conditions. The impaired cAMP synthesisin rat glomeruli using in situ hybridization and Northern
in the high-glucose group dose not seem to be due toblot analysis (data submitted). We also detected mRNAs
decreased number of the receptor because there werefor EP1 and EP4 in rat MCs in this study. The sizes no significant differences in EP4 mRNA levels amongof EP1 mRNA agree with those reported by Okuda- normal-glucose, high-glucose, and mannitol groups.Ashitaka et al [23]. The difference in the tissue distribu-
However, the possible changes of EP receptor proteintion of EP1 mRNA may be due to species differences or levels under high-glucose conditions cannot be ruled outrelatively weak EP1 gene expression in the glomeruli of completely. Further studies to evaluate EP protein inmice and humans. EP3 mRNA has been already reported MCs seem to be necessary to solve this problem.
to be absent in rat glomeruli by in situ hybridization
Recent studies indicate that high glucose concentra-
histochemistry in a previous study [32]. tions activate PKC in glomeruli, MCs, and other tissues,
In the mannitol group, [3H]-thymidine uptake was not and PKC is one of the principal mediators for fibronectin
different from that of the normal-glucose group, al- accumulation by MCs grown in high-glucose medium
though PGE2 accumulation increased as much as that [37–39]. Other studies also suggest that PKC plays piv-
in high-glucose group. Hence, increased [3H]-thymidine otal roles in the initiation and progression of diabetic
uptake by MCs under high-glucose conditions cannot be nephropathy [7, 40–46]. In this context, we examined
explained simply by the overproduction of PGE2. As the the effect of PKC activation by PMA on prostanoid-
EP1 mRNA level was not significantly different between induced cAMP production in MCs. cAMP production
the high-glucose and mannitol group, another mecha- by PGE2 was dose dependently decreased by PMA. In
nism seems to be necessary to induce augmented [3H]- addition, the inhibition of cAMP production under high-
thymidine uptake. It is notable that the effect of PGE2 glucose conditions was partially restored by calphostin
over the range of 1027 m on [3H]-thymidine uptake was C (data not shown). These results suggest that a part of
not statistically different from control, whereas sulpro- the high-glucose–induced inhibition of cAMP produc-
stone or M&B28767 showed a dose-dependent increase tion via EP4 may be mediated by the activation of PKC.
of [3H]-thymidine uptake. The inhibitory effect of PGE2 As EP4 mRNA levels were not decreased in rat MCs
on [3H]-thymidine uptake is thought to be due to the treated with PMA (data not shown), post-transcriptional
production of cAMP by PGE2 because it has been re- modification of the receptor or the change of the activity
ported that cAMP inhibits [3H]-thymidine incorporation of adenylate cyclase by PKC was suggested. PKC has
in rat MCs by suppression of MAPK [33–36]. The sup- been reported to alter both the activity of adenylate
pressive effects of forskolin and db-cAMP also support cyclase isoforms and their responsiveness to G-protein
the inhibitory effect of cAMP on DNA synthesis in MCs. regulation [47]. In the presence of forskolin, PMA treat-
The PGE2-induced elevation of cAMP production ment significantly reduced cAMP concentration com-
from rat MCs is thought to reflect the function of EP4 pared with a PMA nontreated group, indicating the exis-
because butaprost does not stimulate cAMP production tence of a cross-talk between PKC and adenylate cyclase
and Northern blot analysis did not detect EP2 mRNA. in rat MCs. These results suggest that impaired cAMP
Ten210 to 1026 m PGE2 dose dependently increased synthesis in MCs observed at high glucose concentrations
cAMP production, which inhibits DNA synthesis in MCs may be caused by decreased adenylate cyclase activity,
(Fig. 5 A, B). On the other hand, our results indicate a part of which may be induced by the activation of PKC.
that DNA synthesis is induced by PGE2 via EP1, as EP1 This study demonstrates that high-glucose–induced
DNA synthesis of rat MCs can be explained, at least inagonists stimulate DNA synthesis and EP1 antagonists
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